Predicting blood pressure response after renal artery stenting

Journal of Vascular Surgery
Adam W BeckJack L Cronenwett

Abstract

Although technical success of renal artery stenting (RAS) is high and adverse events are infrequent, clinical success (improved blood pressure and renal function) and durability have been less predictable. Identifying those patients who will respond to RAS could improve overall outcomes of the procedure. This was a retrospective analysis of all patients who underwent RAS for treatment of renovascular hypertension (RVH) between 2001 and 2007 at Dartmouth-Hitchcock Medical Center. The primary outcome measure was blood pressure improvement or cure as judged by American Heart Association criteria. Estimated glomerular filtration rate (eGFR), number of antihypertensive medications, and survival were evaluated as secondary outcomes. Univariate and multivariate analyses were performed to identify factors associated with blood pressure improvement at the last follow-up. During the 6-year period, 129 patients (179 renal arteries) underwent stent placement for RVH. Procedural complications occurred nine patients (7.0%). Average length follow-up was 1.5 years. Follow-up data were obtained in 122 patients (95%). At last follow-up, there were significant improvements in systolic blood pressure (161 vs 144 mm Hg, P < .001), diastolic blood p...Continue Reading

References

May 1, 1997·Cardiovascular and Interventional Radiology·F J BeekW P Mali
Dec 31, 1997·Catheterization and Cardiovascular Diagnosis·K HarjaiS Ramee
Jul 11, 2000·Radiology·T C LeertouwerA J Man In 't Veld
Feb 15, 2001·The New England Journal of Medicine·J RadermacherH Haller
Jul 21, 2001·The New England Journal of Medicine·S B Reich
Sep 18, 2002·Circulation·John H RundbackUNKNOWN AHA Councils on Cardiovascular Radiology, High Blood Pressure Research, Kidney in Cardiovascular Disease, Cardio-Thoracic an
Feb 13, 2003·Journal of Vascular and Interventional Radiology : JVIR·Vladimir IvanovicAnthony W Stanson
Aug 23, 2003·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Thomas ZellerFranz-Josef Neumann
Feb 8, 2005·Journal of Vascular Surgery·Brian W NolanJack L Cronenwett
Mar 25, 2005·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Rajesh SubramanianEvgeny Shalman
Jul 14, 2005·Journal of Vascular Surgery·Brian W NolanJack L Cronenwett
Aug 30, 2008·Journal of Vascular Surgery·Matthew A CorriereKimberley J Hansen

❮ Previous
Next ❯

Citations

Jun 1, 2013·Journal of the American Society of Hypertension : JASH·Jacob M StoutDavid E Stec
May 10, 2011·The Canadian Journal of Cardiology·Michael Seddon, Jacqueline Saw
Dec 7, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ido WeinbergMichael R Jaff
May 22, 2013·Journal of Vascular Surgery·Thomas A SimoneBrian W Nolan
Jan 24, 2012·Journal of Vascular Surgery·J Gregory ModrallClayton Trimmer
Dec 3, 2011·Journal of Vascular Surgery·J Gregory ModrallClayton Trimmer
Aug 19, 2011·Human Biology·Tommaso Iannitti, Beniamino Palmieri
May 1, 2019·Current Hypertension Reviews·Chrysoula BoutariAsterios Karagiannis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.